| CASE REPORT |
|
| Year : 2014 | Volume
: 34
| Issue : 2 | Page : 140-142 |
|
|
Capecitabine-induced hand-foot syndrome
Shilpa Y Krishnegowda, Sudhir N Kumar
Department of Dermatology, Venereology and Leprosy, Adichunchanagiri Institute of Medical Sciences, Affiliated to Rajiv Gandhi Institute of Medical Sciences, Karnataka, India
Correspondence Address:
Sudhir N Kumar
MD, Department of Dermatology, Venereology and Leprosy, Affiliated to Rajiv Gandhi Institute of Medical Sciences, Adichunchanagiri Institute of Medical Sciences, Karnataka - 571448
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1110-6530.150277
|
|
|
Capecitabine is an oral fluoropyrimidine carbamate and a prodrug of 5- fluorouracil, used in treatment of colorectal and breast carcinoma, which fail to respond to standard chemotherapies. A variety of muco-cutaneous adverse effects has been recognized. The pathogenesis of such manifestations still remains an enigma though various theories have been proposed. We report a case of localized cutaneous hyperpigmentation of the palms and soles secondary to capecitabine in a woman that underwent sigmoidectomy and was in her second cycle of chemotherapy. Since these drugs causing HFS has become commoner in its use in the recent years, due to its relative ease in administration and the relative unawareness of this syndrome among dermatologists makes it a prudent topic to be reported. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Next article
